Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03910907 · ClinicalTrials.gov registry record
Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis
A clinical trial, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- 10
- Enrollment target
NCT03910907: Clinical Trial study, sponsored by University of Alabama at Birmingham.
NCT03910907 is a clinical trial that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03910907 was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this protocol is to determine the difference in clearance of Mycoplasma genitalium (MG) when using the Australian management protocol versus the current Centers of Disease Control (CDC) treatment guidelines for US standard of care (SOC), to determine the proportion of men from the Deep South, with NGU attributable to MG, and to determine the proportion of MG cases that harbor the macrolide-resistance associated with mutation.
Primary Outcome
DNA negative for mycoplasma
Interventions
- DRUG Comparison of two standard of care regimens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-11-19 |
| Est. Completion | 2020-03-20 |
Why NCT03910907 stopped before completion
NCT03910907 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Comparison of two standard of care regimens is the first listed.
NCT03910907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03910907 about?
NCT03910907 is a clinical study titled "Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis". The purpose of this protocol is to determine the difference in clearance of Mycoplasma genitalium (MG) when using the Australian management protocol versus the current Centers of Disease Control (CDC) treatment guidelines for US standard of care (SOC), to determine the proportion of men from the Dee...
What is the current status of trial NCT03910907?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2019-11-19. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT03910907?
The interventions under investigation include: Comparison of two standard of care regimens (DRUG).
Who is sponsoring clinical trial NCT03910907?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI